Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
NCT ID:
NCT02942550
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of STEMI
* Administration of a 180 mg loading dose ticagrelor
* Analgesic treatment with intravenous morphine pre-PCI
Exclusion Criteria:
* Cardiac arrest
* Body weight \> 114kg
* Vomiting after intake of ticagrelor loading dose
* Use of Naloxone before inclusion or during sampling period
* Inability to understand study outline and instructions
* Methylnaltrexone bromide contraindication
* Age \<18 years; 8) Women in fertile age
* Administration of ticagrelor during the week before inclusion
* Treatment with Cangrexal
* Ongoing long-term opioid treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02942550
Study Brief:
Protocol Section:
NCT02942550